Pulmonx Corp
LUNG- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001127537
In the last 90 days, Pulmonx Corp insiders filed 0 open-market purchases and 4 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $34.1M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Pulmonx Corp as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- +13 vs. Q1 2023
- Shares held
- 33.9M
- −837.0K (−2.4%) vs. Q1 2023
- Total value
- $444.0M
- +$56.0M (+14.4%) vs. Q1 2023
- New holders
- 22
- 41 more added
- Sold out
- 9
- 29 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LUNG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 107 | $34.1M |
| Q1 2026 | 114 | $41.0M |
| Q4 2025 | 112 | $71.6M |
| Q3 2025 | 107 | $51.6M |
| Q2 2025 | 114 | $93.9M |
| Q1 2025 | 115 | $244.3M |
| Q4 2024 | 118 | $243.6M |
| Q3 2024 | 113 | $293.8M |
| Q2 2024 | 112 | $220.5M |
| Q1 2024 | 118 | $321.4M |
| Q4 2023 | 124 | $427.6M |
| Q3 2023 | 117 | $343.8M |
| Q2 2023 | 115 | $444.0M |
| Q1 2023 | 102 | $388.0M |
| Q4 2022 | 116 | $284.6M |
| Q3 2022 | 104 | $581.4M |
| Q2 2022 | 107 | $520.2M |
| Q1 2022 | 109 | $861.1M |
| Q4 2021 | 114 | $1.03B |
| Q3 2021 | 120 | $1.14B |
| Q2 2021 | 113 | $1.14B |
| Q1 2021 | 110 | $988.2M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Pulmonx Corp; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 1,430 | $18.7K | 0.00% | −76−5.0% | Reduced |
| Cubist Systematic Strategies, LLC | 1,410 | $18.5K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 986 | $12.9K | 0.00% | −81−7.6% | Reduced |
| Coppell Advisory Solutions LLC | 1,400 | $10.1K | 0.00% | +1,400 | New |
| Lindbrook Capital, LLC | 369 | $4.84K | 0.00% | 00.0% | Unchanged |
| Quadrant Capital Group LLC | 277 | $3.63K | 0.00% | 00.0% | Unchanged |
| Quantbot Technologies LP | 252 | $3.30K | 0.00% | −34,040−99.3% | Reduced |
| Washington Trust Advisors, Inc. | 167 | $2.19K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 101 | $1.32K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 100 | $1.31K | 0.00% | 00.0% | Unchanged |
| Bell Investment Advisors, Inc | 91 | $1.19K | 0.00% | 00.0% | Unchanged |
| Benjamin F. Edwards & Company, Inc. | 50 | $1.00K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 51 | $1.00K | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 82 | $1.00K | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 75 | $983 | 0.00% | 00.0% | Unchanged |
| Novo Holdings A/S | 0 | $0 | 0.00% | −510,555−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −117,268−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −25,566−100.0% | Sold out |
| Handelsbanken Fonder AB | 0 | $0 | 0.00% | −16,100−100.0% | Sold out |
| Lido Advisors, LLC | 0 | $0 | 0.00% | −13,575−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −13,379−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −4,400−100.0% | Sold out |
| Psagot Value Holdings Ltd. / (Israel) | 0 | $0 | 0.00% | −331−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −17−100.0% | Sold out |